Dayra Therapeutics

Dayra Therapeutics, a startup focused on developing oral macrocyclic peptides for a variety of serious diseases, is pioneering the development of oral macrocyclic peptide therapeutics for the treatment of multiple human diseases. The company combines its macrocycle discovery platform with computational design and modeling to drive the creation of novel macrocyclic peptides capable of selectively targeting disease-related proteins.